Tripped Up; Drugs and Emerging Markets  

Oleh:

[s.n]

Jenis: Article from Bulletin/Magazine
Dalam koleksi: The Economist (http://search.proquest.com/) vol. 404 no. 8801 (Sep. 2012), page 14.
Topik: Pharmaceuticals; Patents; Expenditures; Statistical Data; Emerging Markets

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: EE29.73 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

As economies grow, so do their rates of chronic disease, such as cancer and diabetes. Governments in emerging markets want their citizens to have better drugs. The big pharmaceutical firms are keen to sell to them. But they are fighting bitterly over the terms. Nowhere is the battle more intense than in India. The crucial question is how to protect patents while also expanding access to drugs. These brawls are likely to get worse, with America wanting new protection for drugmakers and China talking about allowing compulsory licensing. America should not use trade deals to swaddle drugmakers in excessive patent protections.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali